ArticleFrontiers in immunology2023

Resistance to anti-PD-1/anti-PD-L1: galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1.

Joseph Mabbitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.